News
EU’s Von der Leyen loses court case over secret Pfizer texts
European Commission President Ursula von der Leyen lost a court fight against attempts to force her to disclose secret text messages with Pfizer’s boss as the bloc was negotiating massive vaccine deals at the height of the Covid-19 pandemic.
Biotech company Alnylam Pharmaceuticals conceded defeat for now in a lawsuit against Pfizer and BioNTech over technology in ...
5hon MSN
We recently published a list of 13 Stocks on Jim Cramer’s Radar Recently. In this article, we are going to take a look at ...
Although the immediate market response was negative, most pharmaceutical stocks recovered after Wall Street analysts ...
But when a dividend yield reaches ultrahigh levels, investors can feel a heightened level of uncertainty. Wondering if Pfizer ...
MedPage Today on MSN1d
Pfizer Confirms: Leading JAK Inhibitor Often Comes With Weight GainPatients taking tofacitinib (Xeljanz) in the drug's late-stage and post-marketing studies were more likely than those on ...
Drugmakers' shares fell globally after President Trump said he would [sign an executive order]( ...
Investing.com -- Moody’s Ratings has assigned an A2 rating to Pfizer Netherlands International Finance B.V. (PNIF BV), a ...
Pfizer's 7.45% dividend yield can't offset weak growth, declining EPS, and patent risks. Read more on PFE and why analysts ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback